ArticleVaccines2026

Prospective Biomarkers of SARS-CoV-2 Vaccine Seroconversion in Patients with Haematological Malignancies.

Sophie C Hamann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.